TrialTrials2017

GA101 (obinutuzumab) monocLonal Antibody as Consolidation Therapy In CLL (GALACTIC) trial: study protocol for a phase II/III randomised controlled trial.

Jamie B Oughton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.